Search
Lapatinib in combination with capecitabine is indicated for patients with HER2 who have previously received advanced or metastatic breast cancer including anthracycline, paclitaxel, and trastuzumab.
Lapatinib is a tyrosine kinase inhibitor that potently inhibits human epidermal growth factor receptor-1 (ErbB1) and human epidermal growth factor receptor-2 (ErbB2) tyrosine kinase activity. It is unique in that it can work through multiple pathways so that breast cancer cells cannot receive the signals needed to grow.
Items | Technical index |
Product name | Lapatinib |
CAS NO. | 231277-92-2 |
Molecular formula | C29H26ClFN4O4S |
Molecular weight | 581.06 |
Appearance | Yellow crystalline powder |
Purity | 98%min |
Product parameters | |
Cas number: | 231277-92-2 |
Appearance: | Yellow crystalline powder |
Purity: | 98%min |
Package details: | 1kg/foil bag; 25kg/drum |
Brand: | Fortunachem |
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail: